Cysteine and glutathione in catabolic conditions and immunological dysfunction
The conspicuous increase in the plasma cysteine disulphide/thiol ratio in elderly persons and cancer patients indicates a shift of the plasma redox state. The most important redox buffers in skeletal muscle tissue and blood plasma, i.e. glutathione and albumin, respectively, are significantly decr...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1999
|
| In: |
Current opinion in clinical nutrition & metabolic care
Year: 1999, Jahrgang: 2, Heft: 3, Pages: 227-233 |
| ISSN: | 1473-6519 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/co-clinicalnutrition/Fulltext/1999/05000/Cysteine_and_glutathione_in_catabolic_conditions.6.aspx
|
| Verfasserangaben: | Wulf Dröge |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1747860867 | ||
| 003 | DE-627 | ||
| 005 | 20230426111242.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210209s1999 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/00075197-199905000-00006 |2 doi | |
| 035 | |a (DE-627)1747860867 | ||
| 035 | |a (DE-599)KXP1747860867 | ||
| 035 | |a (OCoLC)1341392077 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Dröge, Wulf |d -2011 |e VerfasserIn |0 (DE-588)1178587789 |0 (DE-627)1049465539 |0 (DE-576)517837528 |4 aut | |
| 245 | 1 | 0 | |a Cysteine and glutathione in catabolic conditions and immunological dysfunction |c Wulf Dröge |
| 264 | 1 | |c 1999 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.02.2021 | ||
| 520 | |a The conspicuous increase in the plasma cysteine disulphide/thiol ratio in elderly persons and cancer patients indicates a shift of the plasma redox state. The most important redox buffers in skeletal muscle tissue and blood plasma, i.e. glutathione and albumin, respectively, are significantly decreased in different models of cachexia. Treatment with N-acetyl cysteine, i.e. a thiol-containing antioxidant, was found to increase the plasma albumin level and to ameliorate the loss of body cell mass in cancer patients and healthy individuals. The treatment of HIV infection with N-acetyl cysteine, in contrast, serves mainly as a tool to ameliorate the physiological and immunological consequences of the virus-induced cysteine deficiency. | ||
| 773 | 0 | 8 | |i Enthalten in |t Current opinion in clinical nutrition & metabolic care |d London : Lippincott Williams & Wilkins, 1998 |g 2(1999), 3, Seite 227-233 |h Online-Ressource |w (DE-627)324455143 |w (DE-600)2026896-8 |w (DE-576)103189475 |x 1473-6519 |7 nnas |a Cysteine and glutathione in catabolic conditions and immunological dysfunction |
| 773 | 1 | 8 | |g volume:2 |g year:1999 |g number:3 |g pages:227-233 |g extent:7 |a Cysteine and glutathione in catabolic conditions and immunological dysfunction |
| 856 | 4 | 0 | |u https://journals.lww.com/co-clinicalnutrition/Fulltext/1999/05000/Cysteine_and_glutathione_in_catabolic_conditions.6.aspx |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210209 | ||
| 993 | |a Article | ||
| 994 | |a 1999 | ||
| 998 | |g 1178587789 |a Dröge, Wulf |m 1178587789:Dröge, Wulf |d 50000 |e 50000PD1178587789 |k 0/50000/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1747860867 |e 3850189139 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"recId":"1747860867","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 09.02.2021"],"title":[{"title":"Cysteine and glutathione in catabolic conditions and immunological dysfunction","title_sort":"Cysteine and glutathione in catabolic conditions and immunological dysfunction"}],"person":[{"given":"Wulf","family":"Dröge","role":"aut","roleDisplay":"VerfasserIn","display":"Dröge, Wulf"}],"relHost":[{"language":["eng"],"recId":"324455143","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 17.10.05"],"disp":"Cysteine and glutathione in catabolic conditions and immunological dysfunctionCurrent opinion in clinical nutrition & metabolic care","part":{"extent":"7","volume":"2","text":"2(1999), 3, Seite 227-233","pages":"227-233","issue":"3","year":"1999"},"pubHistory":["1.1998 -"],"title":[{"title":"Current opinion in clinical nutrition & metabolic care","title_sort":"Current opinion in clinical nutrition & metabolic care"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1473-6519"],"eki":["324455143"],"zdb":["2026896-8"]},"origin":[{"publisherPlace":"London ; [Erscheinungsort nicht ermittelbar]","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedKey":"1998","dateIssuedDisp":"1998-"}]}],"physDesc":[{"extent":"7 S."}],"id":{"eki":["1747860867"],"doi":["10.1097/00075197-199905000-00006"]},"origin":[{"dateIssuedKey":"1999","dateIssuedDisp":"1999"}],"name":{"displayForm":["Wulf Dröge"]}} | ||
| SRT | |a DROEGEWULFCYSTEINEAN1999 | ||